As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”

Go here to see how you can start accessing these opportunities today

TERN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.10%

Insider Buying (Last 12 Months): $4,999,995.00

Insider Selling (Last 12 Months): $2,961,305.27

Terns Pharmaceuticals Insider Trading History Chart

Terns Pharmaceuticals Share Price & Price History

^$5.79

▲ +0.08 (1.40%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Buffett Dumps $982 Million in BofA Stock—What Does He Know?

From Genesis Gold Group | Ad

Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.

Get your FREE, no-obligation Wealth Protection Guide now

Terns Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/12/2024	Hongbo Lu	Director	Buy	476,190	$10.50	$4,999,995.00	476,190
9/10/2024	Mark J Vignola	CFO	Sell	10,000	$11.00	$110,000.00	91,940
9/9/2024	Jill M Quigley	Director	Sell	17,235	$10.00	$172,350.00	15,000
8/1/2024	Jill M Quigley	Director	Sell	6,143	$7.68	$47,178.24	23,857
7/15/2024	Carl L Gordon	Director	Sell	50,976	$10.00	$509,760.00	756,258
4/3/2024	Vivo Opportunity, Llc	Major Shareholder	Sell	138,066	$6.20	$856,009.20	268,573
4/1/2024	Vivo Opportunity, Llc	Major Shareholder	Sell	181,117	$6.99	$1,266,007.83	275,772
12/23/2022	Orbimed Advisors Llc	Director	Buy	137,931	$7.25	$999,999.75	4,882,854
12/23/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	758,620	$7.25	$5,499,995.00	4,340,212
11/23/2022	Biosciences Fund V L.P. Lav	Major Shareholder	Sell	1,500,000	$5.50	$8,250,000.00	405,583
9/7/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	600,000	$3.60	$2,160,000.00	3,581,592
8/16/2022	Hongbo Lu	Director	Buy	1,500,000	$2.42	$3,630,000.00	2,981,592
8/15/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	1,218	$2.99	$3,641.82	1,481,592
8/12/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	1,123,021	$2.98	$3,346,602.58	1,480,374

2025: Digital Asset Insights You Need to Know

From Darwin | Ad

Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.

Get your guide today!

SEC Filings (Institutional Ownership Changes) for Terns Pharmaceuticals (NASDAQ:TERN)

98.26% of Terns Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Terns Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/20/2024	Virtu Financial LLC	62,216	$0.52M	0.0%	+110.2%	0.073%
11/16/2024	Geode Capital Management LLC	1,207,479	$10.07M	0.0%	+7.6%	1.422%
11/15/2024	Y Intercept Hong Kong Ltd	36,392	$0.30M	0.0%	-42.7%	0.043%
11/15/2024	XTX Topco Ltd	17,696	$0.15M	0.0%	N/A	0.021%
11/15/2024	Wellington Management Group LLP	222,065	$1.85M	0.0%	-0.9%	0.261%
11/15/2024	State Street Corp	1,116,991	$9.32M	0.0%	-5.1%	1.315%
11/15/2024	Point72 Asset Management L.P.	2,707,515	$22.58M	0.1%	+0.6%	3.188%
11/15/2024	Polymer Capital Management HK LTD	24,000	$0.20M	0.0%	N/A	0.028%
11/15/2024	Parkman Healthcare Partners LLC	545,751	$4.55M	0.6%	+39.8%	0.643%
11/15/2024	Ikarian Capital LLC	308,497	$2.57M	0.3%	-32.7%	0.363%
11/15/2024	HighVista Strategies LLC	130,966	$1.09M	0.4%	-11.6%	0.154%
11/15/2024	Cinctive Capital Management LP	168,564	$1.41M	0.1%	N/A	0.198%
11/14/2024	Bellevue Group AG	1,042,135	$8.69M	0.1%	N/A	1.482%
11/14/2024	PDT Partners LLC	37,987	$0.32M	0.0%	-52.7%	0.054%
11/14/2024	Sio Capital Management LLC	10,000	$83K	0.0%	N/A	0.014%
11/14/2024	Walleye Capital LLC	185,795	$1.55M	0.0%	N/A	0.264%
11/14/2024	Martingale Asset Management L P	74,073	$0.62M	0.0%	N/A	0.105%
11/14/2024	Acuta Capital Partners LLC	487,000	$4.06M	3.3%	+31.9%	0.692%
11/13/2024	Quantbot Technologies LP	120,838	$1.01M	0.0%	+3,114.6%	0.172%
11/13/2024	FMR LLC	1,172,524	$9.78M	0.0%	-57.6%	1.667%
11/13/2024	The Manufacturers Life Insurance Company	66,100	$0.55M	0.0%	+191.9%	0.094%
11/12/2024	Telemark Asset Management LLC	300,000	$2.50M	0.3%	N/A	0.427%
11/12/2024	Charles Schwab Investment Management Inc.	154,714	$1.29M	0.0%	+1.3%	0.220%
11/9/2024	Intech Investment Management LLC	17,369	$0.15M	0.0%	N/A	0.025%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	53,013	$0.44M	0.0%	N/A	0.075%
11/7/2024	LMR Partners LLP	20,000	$0.17M	0.0%	N/A	0.028%
11/7/2024	Quest Partners LLC	104,535	$0.87M	0.1%	N/A	0.149%
11/5/2024	Entropy Technologies LP	12,700	$0.11M	0.0%	N/A	0.018%
10/25/2024	China Universal Asset Management Co. Ltd.	13,535	$0.11M	0.0%	+78.1%	0.019%
10/23/2024	E. Ohman J or Asset Management AB	61,775	$0.52M	0.0%	N/A	0.096%
10/16/2024	Bleakley Financial Group LLC	13,312	$0.11M	0.0%	+26.0%	0.021%
10/16/2024	nVerses Capital LLC	5,700	$48K	0.0%	N/A	0.009%
10/11/2024	Creative Planning	25,310	$0.21M	0.0%	+27.2%	0.036%
10/10/2024	Exchange Traded Concepts LLC	106,556	$0.89M	0.0%	+7.9%	0.151%
10/3/2024	SG Americas Securities LLC	23,810	$0.20M	0.0%	N/A	0.034%
8/19/2024	Point72 Asset Management L.P.	2,690,376	$18.32M	0.0%	+21.1%	4.160%
8/15/2024	The Manufacturers Life Insurance Company	22,645	$0.15M	0.0%	+28.7%	0.035%
8/14/2024	Great Point Partners LLC	1,149,406	$7.83M	1.5%	-12.3%	1.777%
8/14/2024	Marshall Wace LLP	25,985	$0.18M	0.0%	-86.0%	0.040%
8/12/2024	Hsbc Holdings PLC	10,157	$71K	0.0%	-27.3%	0.016%
8/9/2024	Renaissance Technologies LLC	87,500	$0.60M	0.0%	N/A	0.135%
8/9/2024	Dimensional Fund Advisors LP	371,892	$2.53M	0.0%	+9.4%	0.575%
8/8/2024	American Century Companies Inc.	64,119	$0.44M	0.0%	+17.7%	0.099%
8/1/2024	Rhumbline Advisers	88,641	$0.60M	0.0%	+50.3%	0.137%
7/26/2024	Bank of New York Mellon Corp	176,673	$1.20M	0.0%	+56.8%	0.273%
7/11/2024	Salem Investment Counselors Inc.	371,600	$2.53M	0.1%	N/A	0.575%
7/10/2024	Simplicity Wealth LLC	10,561	$72K	0.0%	N/A	0.016%
5/20/2024	Virtu Financial LLC	44,307	$0.29M	0.0%	N/A	0.069%
5/17/2024	Walleye Trading LLC	15,000	$98K	0.0%	N/A	0.023%
5/17/2024	Ikarian Capital LLC	88,497	$0.58M	0.1%	-46.5%	0.137%
5/16/2024	California State Teachers Retirement System	32,110	$0.21M	0.0%	-13.2%	0.050%
5/16/2024	Janus Henderson Group PLC	2,003,263	$13.13M	0.0%	+40.6%	3.097%
5/16/2024	Kennedy Capital Management LLC	15,466	$0.10M	0.0%	N/A	0.024%
5/15/2024	Price T Rowe Associates Inc. MD	20,694	$0.14M	0.0%	+12.3%	0.032%
5/15/2024	Affinity Asset Advisors LLC	450,000	$2.95M	0.4%	+581.8%	0.696%
5/14/2024	EntryPoint Capital LLC	13,370	$88K	0.1%	-52.7%	0.021%
5/10/2024	Vanguard Group Inc.	2,199,006	$14.43M	0.0%	+0.5%	3.400%
5/8/2024	Russell Investments Group Ltd.	632,965	$4.15M	0.0%	+127.9%	0.979%
5/7/2024	Swiss National Bank	61,000	$0.40M	0.0%	-10.2%	0.094%
4/29/2024	China Universal Asset Management Co. Ltd.	11,889	$78K	0.0%	+66.3%	0.018%
2/15/2024	Great Point Partners LLC	1,309,975	$8.50M	1.5%	+102.8%	2.120%
2/14/2024	Braidwell LP	2,318,050	$15.04M	0.6%	-18.4%	3.751%
2/14/2024	Pale Fire Capital SE	49,014	$0.32M	0.0%	+222.4%	0.079%
2/13/2024	Affinity Asset Advisors LLC	66,000	$0.43M	0.1%	-79.7%	0.107%
2/12/2024	Decheng Capital LLC	714,285	$4.64M	1.3%	N/A	1.156%
2/9/2024	Franklin Resources Inc.	2,307,834	$14.98M	0.0%	+7.4%	3.735%
2/9/2024	Dynamic Technology Lab Private Ltd	16,322	$0.11M	0.0%	N/A	0.026%
2/6/2024	AJOVista LLC	8,943	$58K	0.1%	N/A	0.014%
2/5/2024	Russell Investments Group Ltd.	277,741	$1.80M	0.0%	N/A	0.449%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	9,350	$61K	0.0%	-16.4%	0.015%
1/29/2024	Simplicity Solutions LLC	10,452	$68K	0.0%	N/A	0.017%
1/25/2024	Bleakley Financial Group LLC	10,452	$68K	0.0%	N/A	0.017%
1/24/2024	China Universal Asset Management Co. Ltd.	7,147	$46K	0.0%	+358.1%	0.012%
11/22/2023	Graham Capital Management L.P.	82,978	$0.42M	0.0%	+186.3%	0.134%
11/15/2023	Acuta Capital Partners LLC	555,260	$2.79M	1.9%	-42.8%	0.909%
11/15/2023	Adage Capital Partners GP L.L.C.	100,000	$0.50M	0.0%	-33.3%	0.164%
11/15/2023	Affinity Asset Advisors LLC	325,000	$1.64M	0.5%	N/A	0.532%
11/14/2023	Braidwell LP	2,840,052	$14.29M	0.4%	+54.2%	4.650%
11/14/2023	PEAK6 Investments LLC	19,097	$96K	0.0%	+35.5%	0.031%
11/14/2023	Pale Fire Capital SE	15,202	$76K	0.0%	N/A	0.025%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	67,957	$0.34M	0.0%	-5.9%	0.111%
11/13/2023	Silverarc Capital Management LLC	500,000	$2.52M	0.8%	-16.6%	0.819%
11/13/2023	FMR LLC	5,118,050	$25.74M	0.0%	-27.4%	8.381%
11/7/2023	Barclays PLC	54,327	$0.27M	0.0%	-79.3%	0.089%
9/21/2023	Barclays PLC	262,918	$2.30M	0.0%	-50.8%	0.431%
9/8/2023	Tucker Asset Management LLC	2,824	$25K	0.0%	N/A	0.005%
8/15/2023	Silverarc Capital Management LLC	599,668	$5.25M	1.6%	-10.2%	0.982%
8/15/2023	Suvretta Capital Management LLC	5,561,835	$48.67M	2.6%	+61.3%	9.107%
8/15/2023	HighVista Strategies LLC	179,670	$1.57M	0.7%	+22.3%	0.294%
8/15/2023	Braidwell LP	1,842,352	$16.12M	0.5%	-7.7%	3.017%
8/14/2023	Deep Track Capital LP	1,099,192	$9.62M	0.4%	N/A	1.800%
8/14/2023	Driehaus Capital Management LLC	1,621,779	$14.19M	0.2%	-34.3%	2.656%
8/14/2023	Graham Capital Management L.P.	28,980	$0.25M	0.0%	N/A	0.047%
8/11/2023	VR Adviser LLC	2,972,869	$26.01M	4.2%	-17.9%	4.868%
8/11/2023	Franklin Resources Inc.	1,484,654	$12.99M	0.0%	+1.9%	2.431%
8/11/2023	Trexquant Investment LP	53,901	$0.47M	0.0%	N/A	0.088%
8/4/2023	American International Group Inc.	20,627	$0.18M	0.0%	N/A	0.036%
8/3/2023	Barclays PLC	262,918	$2.30M	0.0%	-50.8%	0.464%
7/27/2023	Victory Capital Management Inc.	73,930	$0.65M	0.0%	N/A	0.130%
5/15/2023	Atom Investors LP	51,951	$0.62M	0.3%	N/A	0.092%

Data available starting January 2016

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Today's Range

Now: $5.79

$5.54

$5.84

50 Day Range

MA: $7.61

$5.60

$10.21

52 Week Range

Now: $5.79

$3.59

$11.40

Volume

1,010,498 shs

Average Volume

1,373,255 shs

Market Capitalization

$491.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Terns Pharmaceuticals?: Terns Pharmaceuticals' top insider shareholders include:
Orbimed Advisors Llc (Director)
Vivo Opportunity, Llc (Major Shareholder)
Carl L Gordon (Director)
Hongbo Lu (Director)
Biosciences Fund V LP Lav (Major Shareholder)
Mark J Vignola (CFO)
Jill M Quigley (Director)
Learn More about top insider investors at Terns Pharmaceuticals.
Who are the major institutional investors of Terns Pharmaceuticals?: Terns Pharmaceuticals' top institutional shareholders include:
Point72 Asset Management L.P. — 3.19%
Geode Capital Management LLC — 1.42%
FMR LLC — 1.67%
State Street Corp — 1.32%
Bellevue Group AG — 1.48%
Parkman Healthcare Partners LLC — 0.64%
Learn More about top institutional investors of Terns Pharmaceuticals stock.
Which institutional investors are selling Terns Pharmaceuticals stock?: Within the last quarter, TERN stock was sold by these institutional investors:
FMR LLC
Ikarian Capital LLC
State Street Corp
PDT Partners LLC
Y Intercept Hong Kong Ltd
HighVista Strategies LLC
Wellington Management Group LLP
Within the last year, company insiders that have sold Terns Pharmaceuticals company stock include:
Orbimed Advisors Llc (Director)
Vivo Opportunity, Llc (Major Shareholder)
Carl L Gordon (Director)
Hongbo Lu (Director)
Learn More investors selling Terns Pharmaceuticals stock.
Which institutional investors are buying Terns Pharmaceuticals stock?: In the previous quarter, TERN stock was acquired by institutional investors including:
Bellevue Group AG
Telemark Asset Management LLC
Walleye Capital LLC
Cinctive Capital Management LP
Parkman Healthcare Partners LLC
Acuta Capital Partners LLC
Quantbot Technologies LP
Quest Partners LLC
During the last year, these company insiders have bought Terns Pharmaceuticals stock:
Orbimed Advisors Llc (Director)
Vivo Opportunity, Llc (Major Shareholder)
Carl L Gordon (Director)
Learn More investors buying Terns Pharmaceuticals stock.

917 Trades… Zero Losses?

From Insiders Exposed | Ad